BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 7747469)

  • 1. Transcriptional activation by DNA-binding derivatives of HSV-1 VP16 that lack the carboxyl-terminal acidic activation domain.
    Popova B; Bilan P; Xiao P; Faught M; Capone JP
    Virology; 1995 May; 209(1):19-28. PubMed ID: 7747469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
    Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
    EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference with the assembly of a virus-host transcription complex by peptide competition.
    Haigh A; Greaves R; O'Hare P
    Nature; 1990 Mar; 344(6263):257-9. PubMed ID: 2156166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergism between Tat and VP16 in trans-activation of HIV-1 LTR.
    Ghosh S; Selby MJ; Peterlin BM
    J Mol Biol; 1993 Dec; 234(3):610-9. PubMed ID: 8254663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.
    Agostini I; Navarro JM; Rey F; Bouhamdan M; Spire B; Vigne R; Sire J
    J Mol Biol; 1996 Sep; 261(5):599-606. PubMed ID: 8800208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an N-terminal transcriptional activation domain within Brn3b/POU4f2.
    Martin SE; Mu X; Klein WH
    Differentiation; 2005 Feb; 73(1):18-27. PubMed ID: 15733064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C-terminus of the B cell activator Oct-2 functions as an activation domain in yeast.
    Mead J; Elliston K; Mark DF; Ludmerer SW
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1998-2007. PubMed ID: 7811293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal transcriptional activation domain of LZIP comprises two LxxLL motifs and the host cell factor-1 binding motif.
    Luciano RL; Wilson AC
    Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10757-62. PubMed ID: 10984507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single serine residue at position 375 of VP16 is critical for complex assembly with Oct-1 and HCF and is a target of phosphorylation by casein kinase II.
    O'Reilly D; Hanscombe O; O'Hare P
    EMBO J; 1997 May; 16(9):2420-30. PubMed ID: 9171355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the acidic domain of the IE1 regulatory protein from Orgyia pseudotsugata multicapsid nucleopolyhedrovirus.
    Forsythe IJ; Shippam CE; Willis LG; Stewart S; Grigliatti T; Theilmann DA
    Virology; 1998 Dec; 252(1):65-81. PubMed ID: 9875318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of a C. elegans GATA transcription factor, ELT-1, expressed in yeast.
    Shim YH; Bonner JJ; Blumenthal T
    J Mol Biol; 1995 Nov; 253(5):665-76. PubMed ID: 7473742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCF-dependent nuclear import of VP16.
    La Boissière S; Hughes T; O'Hare P
    EMBO J; 1999 Jan; 18(2):480-9. PubMed ID: 9889203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid substitutions in the herpes simplex virus transactivator VP16 uncouple direct protein-protein interaction and DNA binding from complex assembly and transactivation.
    Shaw P; Knez J; Capone JP
    J Biol Chem; 1995 Dec; 270(48):29030-7. PubMed ID: 7499437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bovine herpesvirus alpha gene trans-inducing factor activates transcription by mechanisms different from those of its herpes simplex virus type 1 counterpart VP16.
    Misra V; Walker S; Hayes S; O'Hare P
    J Virol; 1995 Sep; 69(9):5209-16. PubMed ID: 7636962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equid herpesviruses 1 and 4 encode functional homologs of the herpes simplex virus type 1 virion transactivator protein, VP16.
    Purewal AS; Allsopp R; Riggio M; Telford EA; Azam S; Davison AJ; Edington N
    Virology; 1994 Jan; 198(1):385-9. PubMed ID: 8259676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeras of herpes simplex viral VP16 and jun are oncogenic.
    Schuur ER; Parker EJ; Vogt PK
    Cell Growth Differ; 1993 Sep; 4(9):761-8. PubMed ID: 8241024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GAL4-VP16 is an unusually potent transcriptional activator.
    Sadowski I; Ma J; Triezenberg S; Ptashne M
    Nature; 1988 Oct; 335(6190):563-4. PubMed ID: 3047590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in determinants required for complex formation and transactivation in related VP16 proteins.
    Grapes M; O'Hare P
    J Virol; 2000 Nov; 74(21):10112-21. PubMed ID: 11024140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target gene identification: target specific transcriptional activation by three murine homeodomain/VP16 hybrid proteins in Saccharomyces cerevisiae.
    Friedman-Einat M; Einat P; Snyder M; Ruddle F
    J Exp Zool; 1996 Feb; 274(3):145-56. PubMed ID: 8882492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Oct-1 homoeodomain directs formation of a multiprotein-DNA complex with the HSV transactivator VP16.
    Stern S; Tanaka M; Herr W
    Nature; 1989 Oct; 341(6243):624-30. PubMed ID: 2571937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.